Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance

NCT02513732 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02513732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02513732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
September 30, 2020
Enrollment
100 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, coronary artery disease, ischemic heart disease, myocardial ischemia